Abstract:N 6 -methyladenosine (m 6 A) RNA modification is a reversible mechanism that regulates eukaryotic gene expression. Growing evidence has demonstrated an association between m 6 A modification and tumorigenesis and response to immunotherapy. However, the overall influence of m 6 A regulators on the tumor microenvironment and their effect on the response to immunotherapy in lung adenocarcinoma remains to be explored. Here, we comprehensively analyzed the m 6 A modification patterns of 936 lung adenocarcinoma samples based on 24 m 6 A regulators. First, we described the features of genetic variation in these m 6 A regulators. Many m 6 A regulators were aberrantly expressed in tumors and negatively correlated with most tumor-infiltrating immune cell types. Furthermore, we identified three m 6 A modification patterns using a consensus clustering method. m 6 A cluster B was preferentially associated with a favorable prognosis and enriched in metabolism-associated pathways. In contrast, m 6 A cluster A was associated with the worst prognosis and was enriched in the process of DNA repair. m 6 A cluster C was characterized by activation of the immune system and a higher stromal cell score. Surprisingly, patients who received radiotherapy had a better prognosis than patients without radiotherapy only in the m 6 A cluster C group. Subsequently, we constructed an m 6 A score model that qualified the m 6 A modification level of individual samples by using principal component analysis algorithms. Patients with high m 6 A score were characterized by enhanced immune cell infiltration and prolonged survival time and were associated with lower tumor mutation burden and PD-1/CTLA4 expression. The combination of the m 6 A score and tumor mutation burden could accurately predict the prognosis of patients with lung adenocarcinoma. Furthermore, patients with high m 6 A score exhibited greater prognostic benefits from radiotherapy and immunotherapy. This study demonstrates that m 6 A modification is significantly associated with tumor microenvironment diversity and prognosis. A comprehensive evaluation of m 6 A modification patterns in single tumors will expand our understanding of the tumor immune landscape. In addition, our m 6 A score model demonstrated that the level of immune cell infiltration plays a significant role in cancer immunotherapy and provides a basis to increase the efficiency of current immune therapies and promote the clinical success of immunotherapy.

Characterization of m6A regulator‐mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia

Single-cell N6-methyladenosine Regulator Patterns Guide Intercellular Communication of Tumor Microenvironment That Contribute to Colorectal Cancer Progression and Immunotherapy

Analysis of m6A-related signatures associated with the tumor immune microenvironment and predict survival in acute myeloid leukemia

Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia

m5C regulator‐mediated methylation modification patterns and tumor microenvironment infiltration characteristics in acute myeloid leukemia

m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer

m<SUP>6</SUP>A Regulator-Based Methylation Modification Patterns Characterized by Distinct Tumor Microenvironment Immune Profiles in Rectal Cancer

Dynamic alterations of the transcriptome-wide m6A methylome in cytogenetically normal acute myeloid leukaemia during initial diagnosis and relapse

Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma

Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma

m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer

Characterization of m6A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma

The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients

Integrated Analyses of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pan-Cancer

m6A-Related lncRNAs Affect Tumor Immune Microenvironment And Prognosis In Acute Myeloid Leukemia

Methylation Pattern Mediated by m6A Regulator and Tumor Microenvironment Invasion in Lung Adenocarcinoma

N6-Methyladenosine-Related Lncrnas Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia

N6-methyladenosine RNA Modifications: a Potential Therapeutic Target for AML

m 6 A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer